Researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetes.
What do CEOs owe the world?
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello! Today, we discuss